ERIKA DE REYNOSA, S.A. DE C.V. LIBERTY CYCLER SET, SINGLE CONN./EXT. DL; SYSTEM, PERITONEAL, AUTOMATIC DELIVERY
|
Back to Search Results |
|
Catalog Number 050-87216 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Abdominal Pain (1685); Dyspnea (1816); Peritonitis (2252)
|
Event Date 02/10/2024 |
Event Type
Injury
|
Event Description
|
It was reported to fresenius that a patient on peritoneal dialysis (pd) had peritonitis.In additional follow-up, the patient¿s pd nurse stated the patient was experiencing symptoms of abdominal pain and shortness of breath.As a result, on (b)(6) 2024, the patient was admitted to the hospital.Per the nurse, the patient had a pd culture obtained which grew the bacteria staphylococcus aureus and had an elevated white blood cell (wbc) count.Additionally, the patient had fluid volume overload in the setting of pre-existing chronic congestive heart failure.The nurse stated the patient was treated with intra-peritoneal (ip) antibiotic therapy and dialysis (all details unknown) while hospitalized.Subsequently, on (b)(6) 2024, the patient was discharged and was reportedly recovering from the event.The patient was continuing pd therapy with the same cycler without any adverse effects or further issues.The patient¿s nurse confirmed the patient did not have any fluid leaks or issues with fresenius products in relation to the peritonitis and fluid overload event.The nurse indicated the peritonitis is suspected to be due to a breach in aseptic technique during the pd exchange.Additionally, the nurse indicated the fluid volume overload event was due to patient non-compliance to pd therapy.
|
|
Manufacturer Narrative
|
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.Clinical investigation: a temporal relationship exists between pd therapy with the liberty cycler set and the patient¿s hospitalization for peritonitis and fluid volume overload.However, currently there is no allegation nor any objective evidence that a liberty cycler set malfunction or product deficiency was associated with these events.The patient¿s pd nurse reported the patient is non-compliant to pd therapy which is a known risk factor for fluid volume overload in patients with renal failure on dialysis.Moreover, peritonitis is a well-documented complication in patients undergoing pd therapy.The patient¿s pd culture grew the bacteria staphylococcus aureus which is bacteria normally found on human skin.Therefore, based on the reported information, the peritonitis event can be reasonably attributed to a breach in aseptic technique during the pd exchange, as reported by the pd nurse.
|
|
Manufacturer Narrative
|
Plant investigation: the sample was not returned to the manufacturer and the lot number was not provided.A manufacturing review was performed on the products shipped to the patient for the three (3) month time frame which immediately preceded the event occurrence date.This review included the lot numbers for all fresenius liberty cycler sets shipped to this account within the selected time frame.The entire set of lots have been sold and distributed.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.An investigation of the device history records (dhr) was conducted and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The product lots involved met all specifications for release.A review of the dhr did not reveal a probable cause for the customer complaint.As a physical evaluation could not be performed, a definitive conclusion regarding the reported incident could not be reached and a cause could not be confirmed.
|
|
Event Description
|
It was reported to fresenius that a patient on peritoneal dialysis (pd) had peritonitis.In additional follow-up, the patient¿s pd nurse stated the patient was experiencing symptoms of abdominal pain and shortness of breath.As a result, on (b)(6) 2024, the patient was admitted to the hospital.Per the nurse, the patient had a pd culture obtained which grew the bacteria staphylococcus aureus and had an elevated white blood cell (wbc) count.Additionally, the patient had fluid volume overload in the setting of pre-existing chronic congestive heart failure.The nurse stated the patient was treated with intra-peritoneal (ip) antibiotic therapy and dialysis (all details unknown) while hospitalized.Subsequently, on (b)(6) 2024, the patient was discharged and was reportedly recovering from the event.The patient was continuing pd therapy with the same cycler without any adverse effects or further issues.The patient¿s nurse confirmed the patient did not have any fluid leaks or issues with fresenius products in relation to the peritonitis and fluid overload event.The nurse indicated the peritonitis is suspected to be due to a breach in aseptic technique during the pd exchange.Additionally, the nurse indicated the fluid volume overload event was due to patient non-compliance to pd therapy.
|
|
Search Alerts/Recalls
|
|
|